1996 Nobel Prize in Physiology or Medicine
Reason for Award
for their discoveries concerning the specificity of the cell-mediated immune defence
Laureates
Australia
Switzerland
Explanation
Inside our bodies we have tiny soldiers called T cells that fight viruses and bacteria. Mr. Doherty and Mr. Zinkernagel discovered the secret “password” T cells use to find enemies. A T cell will only attack when it sees both the body’s own ID card (the MHC) and the invader’s flag (the antigen) on the same cell. It is like a treasure box that opens only when two keys are turned at the same time. Thanks to this rule, T cells avoid attacking our own healthy cells by mistake.
Related Keywords
T cell
T cells mature in the thymus and comprise subsets such as helper, cytotoxic (killer) and regulatory T cells. Cytotoxic CD8+ T cells destroy infected or cancerous cells, while CD4+ helper T cells modulate immunity through cytokines. The T-cell receptor (TCR) repertoire is diversified by gene rearrangement, enabling recognition of millions of antigens. The Nobel-winning work showed that T-cell antigen recognition requires simultaneous recognition of self MHC. This fundamentally reshaped T-cell biology and fostered wide clinical applications.
Major Histocompatibility Complex (MHC)
MHC molecules are cell-surface glycoproteins that bind antigenic peptides and present them to T cells. Class I is on all nucleated cells, while class II is mainly on professional antigen-presenting cells like dendritic cells. MHC genes are highly polymorphic, influencing transplant compatibility and susceptibility to infection. The Nobel research revealed that T cells recognize only antigens bound to self MHC—“MHC restriction.” This insight has greatly influenced HLA typing, autoimmune disease research and vaccine design.
Antigen presentation
Antigen presentation is the process by which cells bind peptides to MHC molecules and display them for T-cell inspection. In virus-infected cells, proteasome-generated viral peptides are loaded onto MHC class I and surveyed by cytotoxic T cells. Dendritic cells ingest extracellular antigens and present them via MHC class II to activate helper T cells. The Nobel discovery demonstrated that the peptide–MHC complex is the minimal unit required for T-cell activation. This knowledge underpins modern vaccines and immunotherapies.
MHC restriction
MHC restriction is the phenomenon in which T cells respond to an antigenic peptide only when it is bound to a self MHC molecule. This dual recognition is learned during thymic positive and negative selection, allowing self-tolerance and pathogen responsiveness to coexist. The concept is crucial in organ-transplant rejection, vaccine epitope selection and cancer neoantigen therapy. Evasion or breakdown of MHC restriction can contribute to autoimmunity or chronic infection. The finding remains a cornerstone of immunological theory.
Thymic education (positive and negative selection)
In the thymus, immature T cells survive (positive selection) when they bind self-MHC plus self peptide with low affinity, and they are eliminated (negative selection) when the affinity is high. The Nobel discovery of MHC restriction implied that this education process retains T cells that recognize self MHC but have low self-reactivity. The result is a diverse T-cell repertoire capable of rapid pathogen response while preventing autoimmunity. Breakdown of thymic education causes autoimmune diseases such as type 1 diabetes. Recent work has clarified roles of the AIRE gene and thymic epithelial cells in this process.
Immunological synapse
The immunological synapse is a supramolecular structure formed when a T cell contacts an antigen-presenting cell, with TCR-pMHC complexes clustering centrally and adhesion molecules surrounding them. Within the synapse, signaling molecules and the actin cytoskeleton reorganize, determining the strength and duration of T-cell activation. It provides the physical stage for the dual recognition revealed by MHC restriction, and cancer cells or viruses often disrupt synapse formation to evade immunity. The synapse precisely controls calcium signaling, cytokine secretion and perforin release. Studying it aids targeted therapies and understanding immune-evasion mechanisms.